Loading...
XSHG
600518
Market cap3.89bUSD
Dec 05, Last price  
1.99CNY
1D
0.00%
1Q
-1.97%
Jan 2017
-88.85%
IPO
74.47%
Name

Kangmei Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHG:600518 chart
P/E
3,209.65
P/S
5.30
EPS
0.00
Div Yield, %
Shrs. gr., 5y
23.67%
Rev. gr., 5y
-14.63%
Revenues
5.19b
+6.47%
584,613,750825,606,6161,294,056,7331,727,164,1512,377,160,9013,308,801,6406,080,507,22511,165,154,81813,358,728,51715,949,188,76918,066,827,95221,642,324,07017,578,618,64017,065,079,13911,445,545,8105,412,007,9614,152,521,0994,180,150,3294,874,016,1435,189,137,000
Net income
9m
-91.64%
72,646,31399,889,496146,109,126294,575,387501,508,534715,522,7121,005,031,0181,441,191,4881,879,816,9942,285,879,1212,756,734,5983,340,403,6404,100,926,148374,492,320007,917,900,6230102,521,2318,574,000
CFO
-428m
L+34.68%
133,131,86368,318,922162,553,1073,015,266119,466,024669,185,655574,964,0931,008,350,2051,674,010,6281,132,203,880508,863,2251,603,189,3511,842,794,237305,616,7272,882,044,9861,031,392,101214,205,1020-317,521,754-427,633,000
Dividend
Aug 28, 20190.024 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese medicines in China. It also offers chemical drug products; and operates hospitals and Chinese medicine pharmacies. The company was founded in 1997 and is headquartered in Puning, China.
IPO date
Mar 19, 2001
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT